AmpleLogic is a pioneering provider of GAMP (Good Automated Manufacturing Practice) solutions, offering a robust Application Platform as a Service (aPaaS) for the life sciences industry. Since its establishment in 2010, the company has been committed to innovation, developing 12+ products including eQMS, LMS, DMS, eLogs, LIMS, MES, APQR, eBMR, QC Planning, RIMS, and more, aimed at enhancing efficiency and driving market competitiveness within the industry.
AmpleLogic’s flagship product, Electronic Quality Management Software (eQMS), has been instrumental in assisting over 100+ life science companies worldwide in managing quality within regulated environments. The company has forged strong partnerships with major pharmaceutical giants such as Biocon, TEVA, Cipla, Pharos, Ocusoft, Serum Institute of India, and Bharat Biotech.
Based in India, AmpleLogic is dedicated to transforming industries through technology and holds a vision of propelling organizations to new heights of success. Currently, there is no publicly available information about the last investment or investors involved with the company.
There is no investment information
No recent news or press coverage available for AmpleLogic .